<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Cellular prion protein (PrPc) is a <z:chebi fb="0" ids="24410">glycosylphosphatidylinositol</z:chebi>-anchored membrane protein that has various physical functions, including protection against apoptotic and <z:mp ids='MP_0003674'>oxidative stress</z:mp>, cellular uptake of copper ions, transmembrane signaling, and <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> to the extracellular matrix </plain></SENT>
<SENT sid="1" pm="."><plain>In this study, we show that PrPc is highly expressed in colorectal <z:mp ids='MP_0009308'>adenocarcinomas</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>Transcriptome profiling of PrPc-depleted DLD-1 cells revealed downregulation of <z:chebi fb="105" ids="17234">glucose</z:chebi> transporter 1 (Glut1) </plain></SENT>
<SENT sid="3" pm="."><plain>PrPc is shown to be involved in regulating Glut1 expression through the Fyn-HIF-2Î± pathway </plain></SENT>
<SENT sid="4" pm="."><plain>As Glut1 is the natural transporter of <z:chebi fb="105" ids="17234">glucose</z:chebi> and is required for the high glycolytic rate seen in <z:e sem="disease" ids="C0009404" disease_type="Neoplastic Process" abbrv="">colorectal tumors</z:e>, silencing of PrPc reduced the proliferation and survival rate of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cells in vitro </plain></SENT>
<SENT sid="5" pm="."><plain>In vivo, knockdown of PrPc by hydrodynamic injection with a cocktail of PrPc-shRNA-encoding plasmids also inhibited tumorigenicity in a <z:e sem="disease" ids="C1520166" disease_type="Experimental Model of Disease" abbrv="">xenograft model</z:e> in <z:mp ids='MP_0003815'>nude</z:mp> mice </plain></SENT>
<SENT sid="6" pm="."><plain>In summary, our data characterize a novel molecular mechanism that links PrPc expression to the regulation of glycolysis </plain></SENT>
<SENT sid="7" pm="."><plain>Targeting PrPc will therefore be a promising strategy to overcome the growth and survival advantage in <z:e sem="disease" ids="C0009404" disease_type="Neoplastic Process" abbrv="">colorectal tumors</z:e> </plain></SENT>
</text></document>